SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-273957
Filing Date
2021-09-15
Accepted
2021-09-15 16:06:25
Documents
43
Period of Report
2021-09-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d400726d8k.htm   iXBRL 8-K 24585
2 EX-99.1 d400726dex991.htm EX-99.1 22903
3 EX-99.2 d400726dex992.htm EX-99.2 32969
7 GRAPHIC g400726ex99_2s10g1.jpg GRAPHIC 161834
8 GRAPHIC g400726ex99_2s11g1.jpg GRAPHIC 318885
9 GRAPHIC g400726ex99_2s12g1.jpg GRAPHIC 152848
10 GRAPHIC g400726ex99_2s13g1.jpg GRAPHIC 135594
11 GRAPHIC g400726ex99_2s14g1.jpg GRAPHIC 144091
12 GRAPHIC g400726ex99_2s15g1.jpg GRAPHIC 136302
13 GRAPHIC g400726ex99_2s16g1.jpg GRAPHIC 259114
14 GRAPHIC g400726ex99_2s17g1.jpg GRAPHIC 141964
15 GRAPHIC g400726ex99_2s18g1.jpg GRAPHIC 158159
16 GRAPHIC g400726ex99_2s19g1.jpg GRAPHIC 143649
17 GRAPHIC g400726ex99_2s1g1.jpg GRAPHIC 179507
18 GRAPHIC g400726ex99_2s20g1.jpg GRAPHIC 117687
19 GRAPHIC g400726ex99_2s21g1.jpg GRAPHIC 130834
20 GRAPHIC g400726ex99_2s22g1.jpg GRAPHIC 220219
21 GRAPHIC g400726ex99_2s23g1.jpg GRAPHIC 215251
22 GRAPHIC g400726ex99_2s24g1.jpg GRAPHIC 244564
23 GRAPHIC g400726ex99_2s25g1.jpg GRAPHIC 187273
24 GRAPHIC g400726ex99_2s26g1.jpg GRAPHIC 221451
25 GRAPHIC g400726ex99_2s27g1.jpg GRAPHIC 276473
26 GRAPHIC g400726ex99_2s28g1.jpg GRAPHIC 130648
27 GRAPHIC g400726ex99_2s29g1.jpg GRAPHIC 179511
28 GRAPHIC g400726ex99_2s2g1.jpg GRAPHIC 478363
29 GRAPHIC g400726ex99_2s3g1.jpg GRAPHIC 261493
30 GRAPHIC g400726ex99_2s4g1.jpg GRAPHIC 338791
31 GRAPHIC g400726ex99_2s5g1.jpg GRAPHIC 357314
32 GRAPHIC g400726ex99_2s6g1.jpg GRAPHIC 316797
33 GRAPHIC g400726ex99_2s7g1.jpg GRAPHIC 294842
34 GRAPHIC g400726ex99_2s8g1.jpg GRAPHIC 458261
35 GRAPHIC g400726ex99_2s9g1.jpg GRAPHIC 249598
  Complete submission text file 0001193125-21-273957.txt   9329315

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aeri-20210915.xsd EX-101.SCH 2901
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aeri-20210915_lab.xml EX-101.LAB 18139
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aeri-20210915_pre.xml EX-101.PRE 11414
36 EXTRACTED XBRL INSTANCE DOCUMENT d400726d8k_htm.xml XML 3410
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36152 | Film No.: 211255487
SIC: 2836 Biological Products, (No Diagnostic Substances)